Physical activity in statin-treated patients

International Journal of Cardiology

Volumn 134, Issue 1, 2009, Pages 136-137

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b  

^a Sanitary Service   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

Author keywords

Cardiovascular disease; Lifestyle; Physical activity; Statins

Indexed keywords

CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; CREATINE KINASE BLOOD LEVEL; DEATH; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE; HUMAN; LIFESTYLE MODIFICATION; MUSCLE EXERCISE; MUSCLE INJURY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK REDUCTION; WELLBEING;

CARDIOVASCULAR DISEASES; EXERCISE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MOTOR ACTIVITY; MUSCULAR DISEASES;

EID: 64549108539     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.048     Document Type: Article

References (16)

1. World Health Organization. http://www.who.int/moveforhealth/advocacy/information_sheets/sedentary/e n/index.html (accessed October 11, 2007).
2. World Health Organization. http://www.who.int/dietphysicalactivity/ publications/facts/pa/en/index.html (accessed October 11, 2007).
3. Warburton D.E., Nicol C.W., and Bredin S.S. Health benefits of physical activity: the evidence. CMAJ 174 (2006) 801-809
4. Hood D.A., and Saleem A. Exercise-induced mitochondrial biogenesis in skeletal muscle. Nutr Metab Cardiovasc Dis 17 (2007) 332e7
5. LaRosa J.C. Means and ends of statins and low-density lipoprotein cholesterol lowering. J Am Coll Cardiol 50 (2007) 419-420
6. Domanski M.J. Primary prevention of coronary artery disease. N Engl J Med 357 (2007) 1543-1545
7. Mascitelli L., and Pezzetta F. Statins for primary prevention of coronary artery disease. Lancet 369 (2007) 1078-1079
8. Armitage J. The safety of statins in clinical practice. Lancet 370 (2007) 1781-1790
9. Golomb B.A., McGraw J.J., Evans M.A., and Dimsdale J.E. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf 30 (2007) 669-675
10. Sinzinger H., Wolfram R., and Peskar B.A. Muscular side effects of statins. J Cardiovasc Pharmacol 40 (2002) 163-171
11. Thompson P.D., Clarkson P., and Karas R.H. Statin-associated myopathy. JAMA 289 (2003) 1681-1690
12. Draeger A., Monastyrskaya K., Mohaupt M., et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol 210 (2006) 94-102
13. Bruckert E., Hayem G., Dejager S., Yau C., and Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study. Cardiovasc Drugs Ther 19 (2005) 403-414
14. Sinzinger H., and O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol 57 (2004) 525-528
15. Dirks A.J., and Jones K.M. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol 291 (2006) C1208-C1212
16. Schick B.A., Laaksonen R., Frohlich J.J., et al. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther 81 (2007) 650-653